title: Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease.
abstract: OBJECTIVE
  To clarify the relationship of Chlamydia pneumoniae infection and coronary atherosclerosis we studied cell-mediated and humoral immune responses to Chlamydia in 93 patients with angiographically confirmed coronary heart disease and in 115 controls without angiographically demonstrable lesions.
  
  
  RESULTS
  Cell-mediated responses were analysed by measuring lymphocyte proliferative reactivity to whole elementary body antigens of C. pneumoniae. Control antigens included C. trachomatis and purified protein derivative of tuberculin. Chlamydia-specific antibodies were measured using microimmunofluorescence assay. Marked C. pneumoniae-specific immune reactivity, demonstrated by the high incidence of elevated IgG and IgA antibodies and strong lymphocyte proliferative response, was associated with coronary heart disease in male but not in female patients or controls. In male patients, the cell-mediated responses were strong to C. pneumoniae (median stimulation index 9,6) and to C. trachomatis (stimulation index 6,9). The females with coronary heart disease showed significantly stronger cell-mediated responses to C. pneumoniae (stimulation index 6,5) than to C. trachomatis (3,8; P < 0.001) and were comparable to the controls.
  
  
  CONCLUSIONS
  Marked cell-mediated and humoral immunity to C. pneumoniae in males with coronary heart disease suggest that the immune mechanisms triggered by Chlamydia are a possible contributing factor in the disease pathogenesis of coronary atherosclerosis in males. The Chlamydia-specific cell-mediated responses seem to be predominantly induced by antigenic structures that are similar among different Chlamydia-species.
authors.affiliation: National Public Health Institute, Oulu, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Halme
authors.forename: H
authors.initials: H
authors.lastname: Syrjälä
authors.forename: A
authors.initials: A
authors.lastname: Bloigu
authors.forename: P
authors.initials: P
authors.lastname: Saikku
authors.forename: M
authors.initials: M
authors.lastname: Leinonen
authors.forename: J
authors.initials: J
authors.lastname: Airaksinen
authors.forename: H M
authors.initials: HM
authors.lastname: Surcel
mesh_terms: D000907:Antibodies, Bacterial / Q000276:immunology; D000917:Antibody Formation; D000942:Antigens, Bacterial; D016993:Chlamydophila pneumoniae / Q000276:immunology*; D003327:Coronary Disease / Q000276:immunology*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial